Incannex healthcare inc. reports fiscal second quarter 2025 financial results and business updates

New york and melbourne, australia, feb. 14, 2025 (globe newswire) -- incannex healthcare inc. (nasdaq: ixhl), (incannex), a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today reported fiscal second quarter financial results and provided business highlights for the quarter ended december 31, 2024.
IXHL Ratings Summary
IXHL Quant Ranking